Bill Status of HB3454

  1. Home
  2. Legislation
  3. Bill Status

HB3454 - 104th General Assembly

EPINEPHRINE DELIVERY DEVICE
Last Action
4/11/2025 - House: Rule 19(a) / Re-referred to Rules Committee
Statutes Amended In Order of Appearance
20 ILCS 2610/40
50 ILCS 705/10.19
105 ILCS 5/22-30
215 ILCS 5/356z.33
225 ILCS 60/65
410 ILCS 27/1
410 ILCS 27/5
410 ILCS 27/10
410 ILCS 27/15
410 ILCS 27/20
410 ILCS 607/10
410 ILCS 620/3.21from Ch. 56 1/2, par. 503.21
410 ILCS 642/20
Synopsis As Introduced
Amends various Acts to change references from "epinephrine auto-injector" or "epinephrine injector" to "FDA approved epinephrine delivery device or product". Changes the name of the Epinephrine Injector Act to the FDA Approved Epinephrine Delivery Device or Product Act.
Actions
Date Chamber Action
2/07/2025 House Filed with the Clerk by Rep. Joyce Mason
2/18/2025 House First Reading
2/18/2025 House Referred to Rules Committee
3/11/2025 House Assigned to Prescription Drug Affordability & Accessibility Committee
3/19/2025 House Do Pass / Short Debate Prescription Drug Affordability & Accessibility Committee; 013-000-000
3/20/2025 House Placed on Calendar 2nd Reading - Short Debate
3/26/2025 House Added Co-Sponsor Rep. Jawaharial Williams
3/26/2025 House Added Co-Sponsor Rep. Harry Benton
3/26/2025 House Added Co-Sponsor Rep. Dagmara Avelar
3/26/2025 House Second Reading - Short Debate
3/26/2025 House Held on Calendar Order of Second Reading - Short Debate
4/08/2025 House Added Co-Sponsor Rep. Camille Y. Lilly
4/11/2025 House Rule 19(a) / Re-referred to Rules Committee